Combined Synopsis/SolicitationPosted Aug 4, 2026·Responses due Aug 21, 2026

Q301--Cytopathology and Next Generation Sequencing Testing

Veterans Affairs · 242-NETWORK CONTRACT OFFICE 02 (36C242)

Stage
Open solicitation
NAICS
621511
Value
Not stated
Solicitation
36C24226Q0875
Set-aside
None stated
PSC
Q301
Place
Northport, NY, USA
Contact
Mariangie Rivera (Mariangie.Rivera@va.gov)
CSV Email

Capture briefs (a one-page, shareable copy of this page) are part of Pro. The CSV here holds the notice, its timeline and past awards.

Where this opportunity stands

Every notice posted under solicitation 36C24226Q0875 in this department, oldest first.

Early notice
None posted
Solicitation
  • Aug 4, 2026 · this notice
    Combined Synopsis/Solicitation
  • Aug 10, 2026
    Combined Synopsis/Solicitation
    Open
  • Aug 13, 2026
    Combined Synopsis/Solicitation
    Open
  • Aug 19, 2026
    Combined Synopsis/Solicitation
    Open
Award
  • Oct 1, 2026
    Award Notice
    LABORATORY CORPORATION · $1.3M
    Open

Next steps for this stage

Standard steps for the notice type; not advice about this buyer.

  • Decide bid or no bid before the response deadline.
  • Look at the past winners for likely competitors and teaming partners.
  • Follow the opportunity to hear about amendments and the award.

What the notice says

The Department of Veterans Affairs Network Contracting Office (NCO) 2 is seeking to establish an Indefinite Delivery Indefinite Quantity (IDIQ) Contract to provide comprehensive, clinically validated molecular diagnostic testing using NGS to improve the evaluation and management of thyroid nodules with indeterminate FNA cytology, enhancing diagnostic accuracy, reducing unnecessary surgeries, and guiding timely intervention for patients at risk.

Who won similar work

7 award notices on SAM.gov in the last 24 months. Match: Same office, same NAICS 621511.

WinnerAwardsValueLast
QUEST DIAGNOSTICS INCORPORATED · $DGX3$8.1MJun 24, 2026
THE ROGOSIN INSTITUTE INC2$2.3MJun 1, 2026
LABORATORY CORPORATION1$2.4MJun 30, 2026
Eurofins Transplant Genomics, LLC1$600KApr 1, 2026

Value counts single-winner awards. "Shared" awards are multiple-award contracts that list every winner with the same total ceiling; that ceiling is not one company's win, so it is not added in.

Latest awards

Competitive landscape

For the 4 most frequent past winners above. Lobbying is matched by the company's exact name or exact ticker; agencies are as named on the filings.

  • 0 of these past winners lobbied Veterans Affairs, Dept of (VA) since 2024 (0 filings)
  • 0 of their lobbyists list a past Veterans Affairs, Dept of (VA) job
  • $22K from their corporate PACs since 2024 to members of House Committee on Appropriations, House Committee on Veterans' Affairs, Senate Committee on Appropriations, Senate Committee on Veterans' Affairs
  • 0 foreign-agent (FARA) registrations
See who and the source records with Pro

Policy around it

Bills the past winners named while lobbying this agency's issues, rules from the department, and executive orders that name the agency, last 12 months.

  • 0 bills named on the past winners' lobbying filings
  • 25 rules from the department in the last 12 months
  • 0 executive orders naming the agency in the last 12 months
See who and the source records with Pro

Market

For past winners matched exactly to a listed company. Insider trades are open-market buys and sells (Form 4) in the last 90 days, shown as facts; our own study found insiders do not reliably buy ahead of awards.

  • 1 of the past winners are listed companies
  • 0 insider buys and 3 insider sells at them in the last 90 days
See who and the source records with Pro

Sources: SAM.gov notices and award notices; Senate LDA lobbying filings; FEC filings; FARA; Federal Register; congress.gov; SEC Form 4. Every row above links to its record.

Companies are matched to tickers by exact name only. A company we could not match shows no market rows; that is a miss, not a finding.